UM
Identification and optimization of new dual inhibitors of B-Raf and epidermal growth factor receptor kinases for overcoming resistance against vemurafenib
Cheng H.1; Chang Y.3; Zhang L.1; Luo J.1; Tu Z.1; Lu X.1; Zhang Q.3; Lu J.2; Ren X.1; Ding K.1
2014-03-27
Source PublicationJournal of Medicinal Chemistry
ISSN15204804 00222623
Volume57Issue:6Pages:2692-2703
AbstractEpidermal growth factor receptor (EGFR) amplification has been demonstrated to be critical for the inherent and/or acquired resistance against current B-Raf inhibitor therapy for melanoma and colorectal cancer patients. We describe the discovery and structure-activity relationship study of a series of 1H-pyrazolo[3,4-b]pyridine-5-carboxamide analogues as novel dual inhibitors of EGFR and B-Raf mutant. One of the most promising compounds, 6a, potently inhibited both of the kinases with IC values of 8.0 and 51 nM, respectively. The compound also strongly suppressed the proliferation of a panel of intrinsic and acquired resistant melanoma and/or colorectal cancer cells harboring overexpressed EGFR with submicromolar IC values. Further mechanism investigation revealed that 6a could sustainably inhibit the activation of the MAPK path way in the resistant SK-MEL-28 PR30 melanoma cancer cells and WiDr colorectal cancer cells with EGFR amplification. Our results support the hypothesis that the EGFR/B-Raf dual inhibition might be a tractable strategy to overcome the intrinsic and acquired resistance of melanoma and/or colorectal cancers against the current B-Raf inhibitor therapy. © 2014 American Chemical Society.
DOI10.1021/jm500007h
URLView the original
Language英語
Fulltext Access
Citation statistics
Cited Times [WOS]:12   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionUniversity of Macau
Affiliation1.Chinese Academy of Sciences
2.Shenyang Pharmaceutical University
3.Universidade de Macau
Recommended Citation
GB/T 7714
Cheng H.,Chang Y.,Zhang L.,et al. Identification and optimization of new dual inhibitors of B-Raf and epidermal growth factor receptor kinases for overcoming resistance against vemurafenib[J]. Journal of Medicinal Chemistry,2014,57(6):2692-2703.
APA Cheng H..,Chang Y..,Zhang L..,Luo J..,Tu Z..,...&Ding K..(2014).Identification and optimization of new dual inhibitors of B-Raf and epidermal growth factor receptor kinases for overcoming resistance against vemurafenib.Journal of Medicinal Chemistry,57(6),2692-2703.
MLA Cheng H.,et al."Identification and optimization of new dual inhibitors of B-Raf and epidermal growth factor receptor kinases for overcoming resistance against vemurafenib".Journal of Medicinal Chemistry 57.6(2014):2692-2703.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Cheng H.]'s Articles
[Chang Y.]'s Articles
[Zhang L.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Cheng H.]'s Articles
[Chang Y.]'s Articles
[Zhang L.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Cheng H.]'s Articles
[Chang Y.]'s Articles
[Zhang L.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.